Lipopolysaccharide preparation extracted from Porphyromonas gingivalis lipoprotein-deficient mutant shows a marked...

Area of Science:

• Microbiology
• Immunology
• Oral Health

Background:

• Porphyromonas gingivalis is a key pathogen in periodontitis.
• Lipopolysaccharide (LPS) from P. gingivalis activates immune cells via Toll-like receptors (TLRs).
• A previously unidentified lipoprotein (PG1828LP) was found to contribute to LPS-induced cell activation.

Purpose of the Study:

• To investigate the role of PG1828LP in P. gingivalis virulence and immune cell activation.
• To determine if PG1828LP is a major virulence factor.
• To elucidate the contribution of PG1828LP to inflammatory responses.

Main Methods:

• Generation of a PG1828-deficient mutant of P. gingivalis using allelic exchange mutagenesis.
• Purification and characterization of LPS from wild-type and mutant strains.
• Assessment of NF-kappaB activation in TLR2-expressing cells.
• Measurement of cytokine production by human gingival fibroblasts.
• Evaluation of lethal toxicity in a mouse model.

Main Results:

• LPS from the PG1828-deficient mutant (DeltaPG1828-LPS) showed attenuated NF-kappaB activation via TLR2 compared to wild-type LPS (WT-LPS).
• Cytokine production by gingival fibroblasts was decreased by DeltaPG1828-LPS.
• The PG1828-deficient mutant exhibited significantly reduced lethal toxicity in mice compared to the wild-type strain.
• DeltaPG1828-LPS preparation showed no lethal toxicity.

Conclusions:

• PG1828LP is essential for potent inflammatory responses mediated by P. gingivalis.
• PG1828LP is identified as a major virulence factor of P. gingivalis.
• Targeting PG1828LP may offer a therapeutic strategy against P. gingivalis infections.